Goldman Sachs Group Inc Viatris Inc Call Options Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 May 14, 2024	BUY	$8.72 - $11.56 $1.22 Million - $1.62 Million	140,000 Added 46.01%	444,300 $4.95 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $1.22 Million - $1.62 Million	140,000 Added 46.01%	444,300 $4.95 Million
Q3 2022 May 14, 2024	BUY	$8.48 - $11.13 $2.58 Million - $3.39 Million	304,300 New	304,300 $2.59 Million
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $2.58 Million - $3.39 Million	304,300 New	304,300 $2.59 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.